BioXcel Therapeutics, Inc. [BTAI] - and Subsidiaries Chapter 11 Filing
On August 27, 2026, BioXcel Therapeutics, Inc. and its subsidiaries filed for Chapter 11 bankruptcy in the U.S. Bankruptcy Court for the District of Delaware, seeking debtor-in-possession financing from affiliates of Oaktree Capital Management, L.P. and the Qatar Investment Authority to fund post-petition operations.
Why this matters
Generating analysis…